Compare BRFH & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRFH | CTSO |
|---|---|---|
| Founded | 2005 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.3M | 29.3M |
| IPO Year | 2010 | 2008 |
| Metric | BRFH | CTSO |
|---|---|---|
| Price | $1.95 | $0.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $6.00 | $5.38 |
| AVG Volume (30 Days) | 3.7K | ★ 247.4K |
| Earning Date | 05-12-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 10.53 | ★ 65.79 |
| EPS | ★ N/A | N/A |
| Revenue | $211,467.00 | ★ $22,503,908.00 |
| Revenue This Year | $115.22 | $10.34 |
| Revenue Next Year | $16.91 | $22.41 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 92.09 | 48.53 |
| 52 Week Low | $1.92 | $0.35 |
| 52 Week High | $6.08 | $1.22 |
| Indicator | BRFH | CTSO |
|---|---|---|
| Relative Strength Index (RSI) | 36.64 | 45.43 |
| Support Level | N/A | $0.36 |
| Resistance Level | $2.53 | $0.72 |
| Average True Range (ATR) | 0.08 | 0.05 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 13.04 | 29.14 |
Barfresh Food Group Inc develops, manufactures and distributes ready to blend frozen beverages, including smoothies, shakes and frappes for restaurant chains and the foodservice industry. The company's proprietary, patented system uses portion-controlled pre-packaged beverage ingredients that deliver freshly made frozen beverages that are quick, cost efficient, and without waste. Barfresh provides both a single serve solution and a bulk format solution, ideal for high-volume locations. It has seven flavors available as part of its standard line vanilla shake, caribbean smoothie, triple berry smoothie, caramel macchiato frappe, strawberry banana smoothie, mocha frappe and mango burst smoothie and has the development capabilities to deliver custom flavors.
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.